Line 146: | Line 146: | ||
</ul> | </ul> | ||
<br> | <br> | ||
− | + | <!-- | |
<img src="https://static.igem.org/mediawiki/2018/6/6e/T--UCopenhagen--PharMARSy-poster-NiC.jpg"> | <img src="https://static.igem.org/mediawiki/2018/6/6e/T--UCopenhagen--PharMARSy-poster-NiC.jpg"> | ||
− | + | --> | |
</div> | </div> | ||
</div> | </div> |
Revision as of 12:33, 17 October 2018
University of Copenhagen iGEM 2018 Team proudly presents
PharMARSy
A Simple Pharmaceutical Protein Production & Purification System on Mars
"In order to truly explore space, astronauts will need the capability to produce needed medications during their mission" - Virginia Wotring (Adjunct Associate Professor, Center for Space Medicine and Department of Pharmacology and Chemical Biology, Baylor College of Medicine).
The race to the Red Planet has started and colonization could be in the near future! To make the colonization of Mars possible the first people will of course need to be able to survive and be self-sustaining in a place far from Earth. Astronauts will need access to medicine, but bringing it from the Earth is unsustainable. With our project we aim to make a Portable Protein Production and Purification System that will solve the astronauts need for pharmaceutical protein by letting them produce their own medicine on site - no need to depend on the supply from Earth!
How does our system work?
Our protein production system uses the bacterial injectisome (Type III secretion system) as a molecular syringe. The injectisome is a part of certain disease causing bacterias "body" and can be found on e.g. the famous salmonella bacteria, which uses it to inject harmful proteins into mammalian cells. When the bacteria wants to secrete a protein through the injectisome, only specifically tagged proteins carrying a injectisome secretion signal will be able to be secreted. This means that only proteins tagged with that signal are able to use the injectisome. We want to take advantage of that feature by making the bacteria produce useful proteins for us and inject it out through a biomimetic membrane into an isolated collection chamber. When the protein enters the isolated compartment it will theoretically be 100% pure and ready be collected and used for therapeutics.
How does our system differ from conventional protein production?
In conventional protein production the bacteria would produce the protein, but afterwards we would need to go through a lot of steps in order to purify it because the protein is stuck inside the bacteria and would need to be collected before it can be used. The process of purification takes time, lab equipment, chemicals, a lot of water and some of the protein goes to waste. However the method allows for large scale production.
Due to the purification process, conventional protein production requires well equipped labs and are therefore not portable.
Why do we need a portable protein production system for long term space travel?
There are three very important problems with bringing medicine to space:
- Medicine expires after a while, so long term space travel means that at least some of it will be impossible to bring.
- The sheer amount of different medicine astronauts might need is vast which makes it difficult to predict what is needed to bring.
- The cost to keep transporting medicine to sustain a colony or long-term space travel would be unsustainable.
This all makes producing the medicine on-site the far the most attractive solution.
Achievements
Judges Award from Nordic iGEM Conference 2018
iGEMers Choice Award from Nordic iGEM Conference 2018
You can:
- follow our social media: Medium (blog) | Facebook | Twitter | Instagram
- view our poster that we presented at Nordic iGEM conference 2018 in Lund, where we won both the Judges prize and the iGEMers choice award.